Bioperfectus Showcases Its Molecular Diagnostic Products for Infectious Diseases at MEDLAB 2022 Online

By LabMedica International staff writers
Posted on 25 Jan 2022

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) presented its molecular diagnostic products for various infectious diseases at MEDLAB 2022 Online from January 5 to February 28, 2022.

Bioperfectus used its virtual booth to exhibit the STC-96A Real-Time PCR system and STC-96A Plus Real-Time PCR system that are more-than-ever flexible, efficient and reliable breakthrough in the real-time PCR analysis of gene expression and genetic variation. The temperature uniformity of the STC-96A Plus and STC-96A Plus across 96 wells is within a remarkable 0.1℃, which meets all needs for highly precise diagnostic and study use, including High-Resolution Melting Curve (HRM) applications


Image: STC-96A Real-Time PCR System (Photo courtesy of Bioperfectus)

Bioperfectus also highlighted its COVID-19 testing solutions, including the COVID-19 Coronavirus Real Time PCR Kit, an In Vitro Diagnostic (IVD) reagent using fluorescent PCR technology to qualitatively detect Open Reading Frame gene region (ORF1a/b) and viral nucleocapsid region (N) of SARS-CoV-2 RNA from upper and lower respiratory tract specimens. In addition, the company presented the Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit, including Prepacked Extraction Tube, which is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days of the onset of symptoms.

Visitors exploring its online booth also viewed the Nucleic Acid Extraction Solutions produced by Bioperfectus that offer a comprehensive PCR laboratory solution, including SSNP series Nucleic Acid Extraction System (3000A, 2000B & 9600A), Nucleic Acid Extraction Rapid Kit (Magnetic Bead Method) as well as Viral Nucleic Acid Isolation Kit (Silica-Based Spin Column), which integrates new technologies such as machine, electricity and computer software to enable automatic nucleic acid extraction in one time.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.


Latest Medlab 2022 News